TSE:4534Pharmaceuticals
Mochida Pharmaceutical (TSE:4534) Net Margin Rebound Reinforces Bullish Quality Earnings Narrative
Mochida Pharmaceutical (TSE:4534) posted a sharp increase in net profit margin to 5.7%, up from 4.3% last year, with earnings surging 36.5% over the past year. This marks a notable turnaround from its five-year average decline of 12.2% per year. The company’s shares are trading at ¥3,035, below their estimated fair value of ¥5,115.43, but the price-to-earnings ratio stands at 17.9x, commanding a premium to both peers and the broader Japanese pharmaceutical industry. Investors are watching the...